Physiologic frailty
1 paper1 finding
- Humans1
Effects
1Subsequent malignant neoplasms, benign meningiomas, and nonmelanoma skin cancers
no changein humans1
1 study
Subsequent malignant neoplasms, benign meningiomas, and nonmelanoma skin cancers
no changein humans1
Physiologic frailty has no effect on subsequent malignant neoplasms, benign meningiomas, and nonmelanoma skin cancers in humans.
“Physiologic frailty and CIRS-G were not associated with risk of SMNs, meningiomas, or NMSCs.”
Humanssurvivors of childhood cancer
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology20 Jul 2026
More on Subsequent malignant neoplasms, benign meningiomas, and nonmelanoma skin cancers
Latest
6 in 12 monthsCardiovascular Diabetology
Evaluative performance of triglyceride-glucose-frailty index versus surrogate insulin resistance indices for advanced cardiovascular-kidney-metabolic syndrome, cardiometabolic multimorbidity, and mortality: the role of estimated glomerular filtration rate
Cohort study of 11,228 peopleFrailty index
World Journal of Urology
Frailty and comorbidity surpass probable sarcopenia in predicting survival of mCRPC patients treated with first-line ARPIs: a comprehensive geriatric analysis
Cohort study of 213 peopleSarcopenia
Cancer Epidemiology, Biomarkers & Prevention
Accelerated Aging and Risk of Subsequent Neoplasms in Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study
Cohort study in peopleBiomarkers
Journal of Global Health
Impact of social vulnerability on frailty transition among older adults in China: a national two-year cohort study
Study in peoplePopulations
Immunity & Ageing
Extreme MetaboHealth scores in three cohort studies associate with plasma protein markers for inflammation and cholesterol transport
Cohort study in peopleBiomarkers